Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)
Clinical trial NCT06462183 · RECRUITING
Trial details
- NCT number
- NCT06462183
- Sponsor
- Rgenta Therapeutics Inc
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-19
- Primary completion
- 2025-12-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.